Browsing by Author "Turrillas, Pamela"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Adaptation and validation in Chile of the patient identification instrument needing palliative care: NECPAL-CCOMS-ICO 3.1 (c)
    (Springer Science and Business Media Deutschland GmbH, 2021) Troncoso, Jonathan; Morales Meyer, Tina; Villarroel, Luis; Turrillas, Pamela; Rodriguez Nunez, Alfredo
    Objective: Adapt and validate the NECPAL instrument in Chile.
  • No Thumbnail Available
    Item
    Opioid prescribing for cancer pain in Latin America: systematic review
    (2024) Leiva, Ofelia; Chukwusa, Emeka; Nkhoma, Kennedy; Dittborn, Mariana; Turrillas, Pamela; Pastrana, Tania
    Objective To explore opioid prescribing patterns for cancer pain in Latin America (LA).Methods A systematic review was conducted adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Relevant databases, including MEDLINE, EMBASE, PubMed, LILACS and Scielo, were searched from inception to June 2023. Empirical studies of opioid prescription patterns in adult palliative care patients with cancer pain were included. Methodological quality was assessed using the Effective Public Health Practice Project tool. Data were analysed using narrative synthesis. Descriptive statistical analyses were conducted using SPSS V.28 (IBM). Categorical variables were summarised using frequencies and percentages and continuous variables as means or medians.Results Seventeen studies from six countries were included. Ten were observational, while seven were experimental, including five randomised controlled trials (RCT) and two non-RCT. Most were low or moderate methodological quality. Out of 7809 patients, morphine (54%) and tramadol (18%) were the most prescribed opioids. The median of morphine equivalent daily dose was 26 mg (IQR 26-41).Conclusion Latin America shows lower opioid consumption rates compared with high-income countries for control pain management (CPM). More rigorous research on CPM in LA is needed. Additionally, a comprehensive review of opioid prescription patterns, including non-cancer diagnoses, is necessary.